US2022125612A1PendingUtilityA1

Methods, devices, and systems for obesity treatment

73
Assignee: FULFILLIUM INCPriority: Nov 19, 2004Filed: Jun 7, 2021Published: Apr 28, 2022
Est. expiryNov 19, 2024(expired)· nominal 20-yr term from priority
A61F 2250/0002A61F 2250/0003A61F 2/12A61F 2250/008A61B 5/0028A61N 1/372A61B 5/076A61B 5/746A61B 5/7282G08B 21/18A61F 5/0036A61F 2210/0061A61F 5/003A61N 1/08A61F 5/0046A61B 5/686A61B 2560/0276A61F 5/0033
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In one aspect, an obesity treatment device includes multiple inflatable space-filling compartments and a valve system for introducing fluid into each compartment, where the device forms, upon filing the compartments, to a curved shape conforming to a natural three-dimensional kidney shape of the stomach. In one aspect, a method for deploying a gastric balloon structure in a gastric cavity includes determining dimensions of the gastric cavity in a feeding state, selecting a fill volume for each of a number of isolated chambers of the balloon structure, and filling each chamber while the balloon structure is in the gastric cavity. In one aspect, a system for treating obesity includes a means for conforming a flexible, space-filling structure to a natural kidney shape of the gastric cavity, a means for maintaining at least two isolated inflatable regions of the flexible, space-filling structure, and a means for introducing fluid into each inflatable region.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . An improved implantable device having an exterior structure, wherein the improvement comprises a system incorporated into said exterior structure, which system emits a detectable wireless signal upon breach of said exterior structure.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.